Population
Health
DeepHealth Brain
Assess and monitor neurodegenerative changes with quantitative and reference
data
DeepHealth Brain is an AI-powered clinical imaging solution for brain atrophy quantification and white
matter hyperintensities (WMH) detection. It supports the assessment and monitoring of neurodegenerative
changes with quantitative and reference data. FDA-cleared and CE-marked, DeepHealth Brain seamlessly
integrates into existing workflows, with results, reports, and segmentations exported directly to PACS.
It offers flexible deployment options, including on-site or cloud-based installation.
Book a demo
“Using DeepHealth Brain enables us to provide
our
clinicians with valuable objective information derived from our MRI scans. Comparing the
patient's results to a non-biased reference population makes it easier for clinicians to
give patients insights into their atrophy development.”
Mario Muto
Director Diagnostic and Interventional Neuroradiology unit at
Cardarelli Hospital, Naples
“During our MDT meetings, we always pull up
the report from DeepHealth Brain and use it as extra information to come to a joint
decision
on the best diagnosis and clinical management of the patient.“
Meike Vernooij
Professor of Population Imaging at Erasmus MC, Rotterdam
Learn more
Vienna, Austria, Feb. 28, 2024 – Today, DeepHealth, one of the leading providers of radiology informatics and AI solutions, and Incepto, Europe's leading platform for artificial intelligence (AI) solutions applied to medical imaging, announced they are partnering to deliver expanded access to DeepHealth clinical AI and radiology informatics software. The announcement took place at the European Congress of Radiology (ECR 2024) in Vienna, Austria.
What do you know about cloud computing and its role in healthcare settings? In this article, Sham Sokka, Chief Operating and Technology Officer, DeepHealth explores how cloud computing is helping hospitals to adopt new AI technologies that enhance patient care.
Los Angeles, CA/Somerville, MA, February 25, 2025 – DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT) and ConcertAI’s TeraRecon, a leader in medical imaging advanced visualization, clinical AI, and workflow automation, announced today a strategic collaboration to integrate certain capabilities to advance imaging tools and the radiology workflow.
Disclaimers:
DeepHealth Brain is manufactured as Quantib ND by Quantib BV for DeepHealth Inc.
Not all products and functionalities are commercially available in all countries. For clearance and commercial
availability in your geography of functionalities listed and compatibility with other systems, please
contact us.